Granuflo MDL News – Advantages of Fresenius Dialysis Lawsuit Loans

Ava Lawson | July 11th, 2013

Fresenius Dialysis Lawsuit Loans This past April, a federal panel moved to consolidate lawsuits alleging injuries from dialysis products Granuflo and Naturalyte, owing to the sheer number of complaints citing similar complications. The multidistrict litigation was established in Massachusetts district court where Fresenius Medical Care will be defending its controversial dialysates. Designated as MDL No. 2428, the mass litigation continues to grow as more claims are filed alleging cardiovascular complications, heart attack, stroke and sudden death.

On June 21, six plaintiff attorneys filed a motion asking the presiding Judge Woodlock to program an initial case management conference and determine leadership positions for counsel representing all plaintiffs in the consolidated litigation. Individuals who’ve filed Granuflo lawsuits against Fresenius can expect a long wait before their claims resolve, as MDL proceedings can be exceedingly lengthy  – often months or years before any cases make it to trial.

If protracted litigation has you contemplating an unfair Granuflo settlement, this is your cue to consider Fresenius dialysis lawsuit loans with LawStreet Capital. Medical expenses, lost wages and diminished earnings can place enormous financial burdens on injured plaintiffs. With the aid of Granuflo legal funding, claimants can rest assured their bills will be paid while they wait for their day in court.

Fresenius dialysis lawsuit loans: a solution to your financial worries

At present, Fresenius is facing over 300 product liability lawsuits involving Granuflo and Naturalyte, and the MDL court docket will likely expand as more dialysis patients seek compensation for their injuries or the death of a loved one.  After the FDA issued a Class I recall of Granuflo and Naturalyte in March 2012, an increasing number of dialysis patients became aware of the product’s dangerous side effects. Fresenius is being held liable for failing to warn of Granuflo risks, as internal documents show the manufacturer was aware of such hazards by 2011, but failed to caution health care providers and physicians who administered the dialysates.

According to the June 21 motion, Judge Woodlock has been asked to appoint a plaintiffs’ Executive Committee and an 11-member plaintiffs’ Steering Committee to manage activities in the Granuflo MDL. While multidistrict litigation is established to streamline the discovery process and all pre-trial proceedings, the process is slow and methodical.  Even if mediation talks are ordered, plaintiffs could be looking at another year before their lawsuits are resolved.  During such difficult times, claimants can rely on Fresenius dialysis lawsuit loans to help them bridge the gap between today’s financial struggles and tomorrow’s jury verdict or settlement.

LawStreet Capital is a direct lender

Why consider legal funding with LawStreet Capital? The answer is easy: with no middleman to inflate interest rates, you can get the best deal in the industry. Some other benefits of working with us:

  • Free online application with no hidden costs
  • 24-hour approval process
  • No collateral needed
  • Funds available overnight
  • 100% risk free:  you only repay the advance if you win!
  • No monthly fees
  • Low interest rates

Cash for Granuflo lawsuit plaintiffs

Without the assistance of Fresenius dialysis lawsuit loans, some plaintiffs may feel trapped into accepting a lower settlement from the defendant. One of the best aspects about Granuflo legal funding is that the cash advance is non-recourse, meaning you only pay back the loan if you win your case. At LawStreet Capital, we can approve your application in as fast as 24 hours with no credit or employment checks and no hassles. The only proof required is a strong case against Fresenius Medical Care, as your lawsuit funding is based on the success of your pending claim. The application is free; to start the process, please fill out the form to your right or call 1.866.FUND.662